Haemonetics Corporation
DE ˙ DB ˙ US4050241003
59,00 € ↑3,00 (5,36%)
2026-06-04
AKTIENPREIS
SecurityDE:HAZ / Haemonetics Corporation
InstitutionBlackRock, Inc.
Latest Disclosed Ownership6,056,881 shares
Ownership 11.90%
BlackRock, Inc. ownership in HAZ / Haemonetics Corporation

2024-01-23 - BlackRock, Inc. has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,056,881 shares of Haemonetics Corporation (DE:HAZ). This represents 11.9 percent ownership of the company. In their previous filing dated 2023-01-26 , BlackRock, Inc. had reported owning 5,898,620 shares, indicating an increase of 2.68 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2024-01-23 2024-01-23 13G/A 5,898,620 6,056,881 2.68 11.90 1.71
2023-01-26 2023-01-26 13G/A 5,898,620 5,898,620 0.00 11.70 0.00
2023-01-20 2023-01-20 13G/A 6,692,346 5,898,620 -11.86 11.70 -10.69
2022-01-27 2022-01-27 13G/A 6,692,346 6,692,346 0.00 13.10 0.00
2022-01-25 2022-01-25 13G/A 5,979,303 6,692,346 11.93 13.10 11.97
2021-07-12 2021-07-12 13G/A 4,700,591 5,979,303 27.20 11.70 25.81
2021-01-29 2021-01-29 13G/A 5,910,860 4,700,591 -20.48 9.30 -20.51
2020-02-04 2020-02-04 13G/A 6,026,806 5,910,860 -1.92 11.70 0.00
2019-01-28 2019-01-28 13G/A 6,670,988 6,026,806 -9.66 11.70 -7.14
2018-01-19 2018-01-19 13G/A 5,890,641 6,670,988 13.25 12.60 10.53
2017-01-12 2017-01-12 13G/A 5,224,978 5,890,641 12.74 11.40 11.76
2016-09-09 2016-09-09 13G/A 4,790,386 5,224,978 9.07 10.20 8.51
2016-01-26 2016-01-26 13G/A 4,790,386 9.40
2015-01-22 2015-01-22 13G/A 4,471,709 8.70
2014-01-29 2014-01-29 13G/A 4,486,112 8.70
2013-02-01 2013-02-01 13G/A 4,277,581 8.29
2012-02-13 2012-02-13 13G/A 1,887,177 7.55

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F HAEMONETICS CORP MASS COM 405024100 5,619,979 -200,975 -3.45 316,742 -32.11 0.0055
2026-02-12 2025-12-31 13F HAEMONETICS CORP MASS COM 405024100 5,820,954 -199,724 -3.32 466,549 58.99 0.0079
2025-11-12 2025-09-30 13F HAEMONETICS CORP MASS COM 405024100 6,020,678 -344,100 -5.41 293,448 -38.21 0.0051
2025-08-12 2025-06-30 13F HAEMONETICS CORP MASS COM 405024100 6,364,778 7,614 0.12 474,876 17.54 0.0090
2025-05-02 2025-03-31 13F HAEMONETICS CORP MASS COM 405024100 6,357,164 197,260 3.20 403,998 -16.00 0.0085
2025-02-07 2024-12-31 13F HAEMONETICS CORP MASS COM 405024100 6,159,904 -54,472 -0.88 480,965 -3.71 0.0097
2024-11-13 2024-09-30 13F HAEMONETICS CORP MASS COM 405024100 6,214,376 255,263 4.28 499,512 1.32 0.0105
2024-08-13 2024-06-30 13F HAEMONETICS CORP MASS COM 405024100 5,959,113 -25,268 -0.42 492,997 -3.48 0.0112
2024-05-10 2024-03-31 13F HAEMONETICS CORP MASS COM 405024100 5,984,381 -55,636 -0.92 510,767 -1.11 0.0119
2024-02-13 2023-12-31 13F HAEMONETICS CORP MASS COM 405024100 6,040,017 258,268 4.47 516,482 -0.28 0.0132
2023-11-13 2023-09-30 13F HAEMONETICS CORP MASS COM 405024100 5,781,749 -32,661 -0.56 517,929 4.62 0.0149
2023-08-11 2023-06-30 13F HAEMONETICS CORP MASS COM 405024100 5,814,410 38,873 0.67 495,039 3.58 0.0136
2023-05-12 2023-03-31 13F HAEMONETICS CORP MASS COM 405024100 5,775,537 -98,420 -1.68 477,926 3.45 0.0141
2023-02-13 2022-12-31 13F HAEMONETICS CORP MASS COM 405024100 5,873,957 334,707 6.04 461,987 12.66 0.0145
2022-11-14 2022-09-30 13F HAEMONETICS CORP MASS COM 405024100 5,539,250 -45,185 -0.81 410,072 12.66 0.0139
2022-08-12 2022-06-30 13F HAEMONETICS CORP MASS COM 405024100 5,584,435 -367,290 -6.17 363,993 -3.26 0.0117
2022-05-12 2022-03-31 13F HAEMONETICS CORP MASS COM 405024100 5,951,725 -740,621 -11.07 376,267 6.00 0.0101
2022-02-10 2021-12-31 13F HAEMONETICS CORP MASS COM 405024100 6,692,346 -298,196 -4.27 354,962 -28.07 0.0090
2021-11-09 2021-09-30 13F HAEMONETICS CORP MASS COM 405024100 6,990,542 1,011,239 16.91 493,464 23.84 0.0138
2021-08-11 2021-06-30 13F HAEMONETICS CORP MASS COM 405024100 5,979,303 1,181,697 24.63 398,462 -25.18 0.0111
2021-05-07 2021-03-31 13F HAEMONETICS CORP MASS COM 405024100 4,797,606 97,015 2.06 532,581 -4.59 0.0157
2021-02-05 2020-12-31 13F HAEMONETICS COM 405024100 4,700,591 -191,334 -3.91 558,195 30.78 0.0178
2020-11-06 2020-09-30 13F HAEMONETICS COM 405024100 4,891,925 -203,677 -4.00 426,821 -6.47 0.0158
2020-08-14 2020-06-30 13F HAEMONETICS COM 405024100 5,095,602 -877,406 -14.69 456,365 -23.33 0.0182
2020-05-01 2020-03-31 13F HAEMONETICS COM 405024100 5,973,008 62,148 1.05 595,270 -12.35 0.0291
2020-02-13 2019-12-31 13F HAEMONETICS COM 405024100 5,910,860 46,733 0.80 679,157 -8.18 0.0260
2019-11-08 2019-09-30 13F HAEMONETICS COM 405024100 5,864,127 -134,488 -2.24 739,700 2.47 0.0311
2019-08-22 2019-06-30 13F/A-1 HAEMONETICS COM 405024100 5,998,615 -386,622 -6.05 721,874 29.23 0.0309
2019-08-13 2019-06-30 13F HAEMONETICS COM 405024100 5,998,615 -386,622 721,874
2019-05-09 2019-03-31 13F HAEMONETICS COM 405024100 6,385,237 358,431 5.95 558,580 -7.36 0.0249
2019-02-08 2018-12-31 13F HAEMONETICS COM 405024100 6,026,806 92,894 1.57 602,982 -11.31 0.0304
2018-11-09 2018-09-30 13F HAEMONETICS COM 405024100 5,933,912 -74,581 -1.24 679,909 26.18 0.0294
2018-08-09 2018-06-30 13F HAEMONETICS COM 405024100 6,008,493 -916,433 -13.23 538,843 6.36 0.0248
2018-05-09 2018-03-31 13F HAEMONETICS COM 405024100 6,924,926 253,938 3.81 506,627 30.76 0.0242
2018-02-09 2017-12-31 13F HAEMONETICS COM 405024100 6,670,988 225,160 3.49 387,452 33.96 0.0184
2017-11-14 2017-09-30 13F HAEMONETICS COM 405024100 6,445,828 190,150 3.04 289,225 17.08 0.0146
2017-08-10 2017-06-30 13F HAEMONETICS COM 405024100 6,255,678 -34,050 -0.54 247,036 -3.19 0.0131
2017-05-12 2017-03-31 13F HAEMONETICS COM 405024100 6,289,728 6,276,880 48,854.92 255,175 49,256.87 0.0140
2017-02-10 2016-12-31 13F HAEMONETICS COM 405024100 12,848 -1,155 -8.25 517 1.97 0.0007
2016-11-08 2016-09-30 13F HAEMONETICS COM 405024100 14,003 712 5.36 507 31.69 0.0007
2016-08-10 2016-06-30 13F HAEMONETICS COM 405024100 13,291 9,790 279.63 385 215.57 0.0006
2016-05-10 2016-03-31 13F HAEMONETICS COM 405024100 3,501 1,950 125.73 122 144.00 0.0002
2016-02-11 2015-12-31 13F HAEMONETICS COM 405024100 1,551 403 35.10 50 35.14 0.0001
2015-11-13 2015-09-30 13F HAEMONETICS COM 405024100 1,148 -3,507 -75.34 37 -80.83 0.0001
2015-08-07 2015-06-30 13F HAEMONETICS COM 405024100 4,655 -727 -13.51 193 -20.25 0.0003
2015-05-13 2015-03-31 13F HAEMONETICS COM 405024100 5,382 -422 -7.27 242 11.52 0.0003
2015-02-09 2014-12-31 13F HAEMONETICS COM 405024100 5,804 263 4.75 217 12.44 0.0003
2014-10-29 2014-09-30 13F HAEMONETICS COM 405024100 5,541 -10,518 -65.50 193 -65.96 0.0003
2014-08-06 2014-06-30 13F HAEMONETICS COM 405024100 16,059 10,090 169.04 567 190.77 0.0008
2014-05-02 2014-03-31 13F HAEMONETICS COM 405024100 5,969 4,316 261.10 195 178.57 0.0003
2014-02-12 2013-12-31 13F HAEMONETICS COM 405024100 1,653 -45 -2.65 70 2.94 0.0001
2013-11-12 2013-09-30 13F HAEMONETICS COM 405024100 1,698 42 2.54 68 -1.45 0.0001
2013-08-13 2013-06-30 13F HAEMONETICS COM 405024100 1,656 1,656 69 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.